anubhai
Back OfficeBajaj Finserv Healthcare Fund - Regular (G)
Summary
| Fund Name | Bajaj Finserv Mutual Fund |
| Scheme Name | Bajaj Finserv Healthcare Fund - Regular (G) |
| AMC | Bajaj Finserv Mutual Fund |
| Type | Open |
| Category | Equity - Pharma |
| Launch Date | 06-Dec-2024 |
| Fund Manager | Vinay Bafna |
| Net Assets(Rs. cr) | 332.52 |
NAV Graph
| One Month | Three Month | Six Month | One Year | Three Year | Five Year |
Latest Payouts
| Dividends | Bonus |
|---|
Performance
| 1 Week (%) | 1 Month (%) | 3 Month (%) | 6 Month (%) | 1 Year (%) | 3 Year (%) | 5 Year (%) | Since INC (%) | |
|---|---|---|---|---|---|---|---|---|
| Scheme Return | 1.26 | 3.06 | 12.11 | 8.05 | 9.04 | 0.00 | 0.00 | 3.45 |
| Category Avg | -1.49 | 3.96 | 6.41 | 5.16 | 10.01 | 23.45 | 13.95 | 14.83 |
| Category Best | -0.03 | 6.29 | 10.67 | 11.80 | 20.14 | 27.29 | 16.39 | 29.33 |
| Category Worst | -2.63 | -0.92 | -0.54 | -2.67 | 1.78 | 19.10 | 10.36 | -1.68 |
Asset Allocation
Holdings
| Company Name | % Hold |
|---|---|
| Divi's Lab. | 9.07 |
| Apollo Hospitals | 6.73 |
| Sun Pharma.Inds. | 6.54 |
| Piramal Pharma | 6.51 |
| Aurobindo Pharma | 6.17 |
| Torrent Pharma. | 5.26 |
| Rubicon Research | 4.52 |
| Neuland Labs. | 4.39 |
| Emcure Pharma | 4.18 |
| Max Healthcare | 3.68 |
| Fortis Health. | 3.36 |
| Zydus Wellness | 2.65 |
| Vijaya Diagnost. | 2.43 |
| Ipca Labs. | 2.31 |
| Shaily Engineer. | 2.23 |
| Navin Fluo.Intl. | 2.14 |
| Laurus Labs | 2.05 |
| Senores Pharma. | 2.05 |
| Sanofi Consumer | 1.91 |
| Glenmark Pharma. | 1.90 |
| Dr Lal Pathlabs | 1.70 |
| Glaxosmi. Pharma | 1.58 |
| Biocon | 1.48 |
| Zydus Lifesci. | 1.46 |
| Abbott India | 1.40 |
| Medplus Health | 1.39 |
| Krishna Institu. | 1.14 |
| Medi Assist Ser. | 1.12 |
| ERIS Lifescience | 1.05 |
| Jubilant Pharmo | 1.05 |
| ICICI Pru Life | 0.91 |
| Astrazeneca Phar | 0.85 |
| MTAR Technologie | 0.59 |
| C C I | 1.53 |
| Net CA & Others | 1.12 |
| Bajaj Finserv Money Market Fund - Direct (G) | 1.55 |
